[1] DANIEL AOWICKI Adam H. Structure and antimicrobial properties of monensin A and its derivatives: summary of the achievements.[J]. BioMed Research International, 2013: 742149. DOI:
10.1155/2013/742149[2] WILLIAM J JO SIU. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.[J]. Antimicrobial Agents and Chemotherapy, 2013, 57 4: 1610-1616. DOI:
10.1128/aac.02056-12[3] C G CESCHIN-ROQUES. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.[J]. Skin pharmacology : the official journal of the Skin Pharmacology Society, 1991, 4 2: 89-94. DOI:
10.1159/000210929[4] HONGYU ZHOU. The antitumor activity of the fungicide ciclopirox[J]. International Journal of Cancer, 2010, 127 10: 2467-2477. DOI:
10.1002/ijc.25255[5] SANTHOSH M BABY. Effects of hypoxia and intracellular iron chelation on hypoxia-inducible factor-1alpha and -1beta in the rat carotid body and glomus cells.[J]. Histochemistry and Cell Biology, 2003, 120 5: 343-352. DOI:
10.1007/s00418-003-0588-2